Machine Learning Dosis Demonstrates 40% Reduction in Epoetin Beta Utilization with Maintained Hemoglobin Levels AIT News Desk Oct 17, 2022 Dosis, a market leader in artificial intelligence-powered precision dosing, announced the publication of two abstracts to be showcased at the American…